Evia Bio, Inc.
New Form D on file · 2026-09-28 · the record
Evia Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2026-09-28.
Evia Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 28, 2026. The filing reports $5.45M sold. Its industry group is Biotechnology. It names Jeffrey Allen (Executive Officer, Director), Marc Centrella (Director), Scott Fisher (Director) (SEC Form D, September 28, 2026).
Sell to companies like Evia Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Evia Bio, Inc. raised on Sep 28. 137 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Linework USA INC. | $1.2B | AI and software |
| Linework USA INC. | $326M | AI and software |
| Pathos AI, Inc. | $238M | Biotech |
| Galvanize Therapeutics, Inc. | $136M | Biotech |
| Tractian Inc. | $106M | AI and software |
Selling to Evia Bio, Inc.? See who runs it and how to reach them, plus this week's 162 other newly funded companies.
Is this your company?
New Form D on file · 2026-09-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Evia Bio, Inc.
Free to see. No signup.
More on the people and the money behind Evia Bio, Inc., from the filings we hold.
Biotechnology raises by companies based in Minnesota, filed within 90 days of this one, largest first.
Get an email when Evia Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Evia Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Evia Bio, Inc. →Get the full cited report on Evia Bio, Inc.
What the filing shows about Evia Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Evia Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The weeks after a raise are when investors, other founders and press look Evia Bio, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Evia Bio, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.
The filing gives Evia Bio, Inc.'s address as 2001 6th Street Se, Room 2-434 Bench 33, Minneapolis, MN 55455.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Evia Bio, Inc. is a registered filer with the SEC (CIK 1954759) and has filed since 2026-09-28. 1 filing is on record, the latest on 2026-09-28.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Evia Bio, Inc.'s Form D of 2026-09-28 names Jeffrey Allen, Marc Centrella, Scott Fisher and 2 more as its officers, directors or promoters.
Its new offerings report $5.45M sold across 1 offering, as its own filings state.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $5.45M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Accrued consulting fees.
Jeffrey Allen is named as Executive Officer and Director on the Form D that Evia Bio, Inc. filed with the SEC on 28 September 2026, one of 5 people that filing names.
Marc Centrella is named as Director on the Form D that Evia Bio, Inc. filed with the SEC on 28 September 2026, one of 5 people that filing names.
Scott Fisher is named as Director on the Form D that Evia Bio, Inc. filed with the SEC on 28 September 2026, one of 5 people that filing names.
Allison Hubel is named as Director on the Form D that Evia Bio, Inc. filed with the SEC on 28 September 2026, one of 5 people that filing names.
Troy Wichterman is named as Director on the Form D that Evia Bio, Inc. filed with the SEC on 28 September 2026, one of 5 people that filing names.
5 people named on the filing — 1 holding an executive role and 4 as directors only.
Named as of the 2026-09-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Evia Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Evia Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Evia Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Evia Bio, Inc.You get an alert in MentionFox the next time this company shows up.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Evia Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-09-28 · Biotech raises in Minneapolis-St. Paul
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/evia-bio-inc-form-d-000004